HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NACDS In Brief

This article was originally published in The Tan Sheet

Executive Summary

Aleve liqui-gels: Bayer's launch of Aleve liqui-gels demonstrates the growing popularity of the formulation on the market. The product, which contains naproxen sodium 220 mg, will make its marketplace debut in 20-, 40- and 80-count packages in January 2007, the firm announces at the National Association of Chain Drugstores Marketplace conference and tradeshow in San Diego, Calif. June 24-27. A TV and print ad campaign will support the launch, Bayer says. Aleve currently is available in tablets, caplets and gelcaps. Wyeth's Advil liqui-gels saw a 25% sales increased in early 2005, despite concerns about NSAID use (1"The Tan Sheet" July 25, 2005, p. 5)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

RS125850

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel